Telehealth ADHD assessment exploded after COVID-era prescribing flexibilities. Some services offer thoughtful, well-credentialed clinicians and reasonable pricing. Others have had federal investigations, paused stimulant prescribing, or significant patient complaints. The marketing copy of all of them looks similar. Here's how to tell them apart.

The non-negotiables

1. The clinician you'll see is licensed and credentialed

Verify the clinician seeing you is a licensed psychiatrist (MD/DO), psychologist (PhD/PsyD), psychiatric nurse practitioner (PMHNP), or licensed clinical social worker (LCSW) where appropriate. Reputable services name their clinicians and provide license verification. If a service won't tell you who you're seeing or what their credentials are until after you've paid, that's a flag.

2. The assessment includes a structured diagnostic interview, not just a form

A legitimate ADHD assessment includes (at minimum) a structured clinical interview, a developmental history, and standardized rating scales. A 5-minute form-fill that produces a prescription is not an assessment. Be explicit: ask "How long is the diagnostic visit? Is it asynchronous or video-based? What scales do you use?"

3. The service treats differential diagnosis seriously

A good clinician will ask about anxiety, depression, sleep, trauma, substance use, family history, and developmental history — not just ADHD-specific symptoms. If a service doesn't ask any differential questions, the assessment is too thin.

4. The follow-up cadence is appropriate, not minimal

Adequate ADHD treatment includes follow-up visits during titration (typically monthly for the first 3–6 months), with longer intervals once stable. If a service's plan only includes one follow-up at 6 months while you're starting on a stimulant, that's inadequate.

Regulatory and operational red flags

  • Federal investigations or DEA actions. Specific services have had public regulatory issues — Done's founder was indicted in 2024; Cerebral was investigated in 2022. Search current news for "[service name] DEA" or "[service name] investigation" before committing.
  • Recent suspension of controlled-substance prescribing. If a service has paused or significantly restricted Schedule II prescribing, that often reflects a regulatory or legal pressure response. Sometimes warranted, sometimes a sign of broader practice issues.
  • Pressure tactics for ongoing subscriptions. Some services structure pricing to lock you in to monthly payments regardless of whether you need monthly visits. Read the cancellation terms before you start.
  • No clear pathway for non-stimulant fit. If the only reason a service exists is to prescribe stimulants quickly, it has misaligned incentives. A service that's equally willing to prescribe non-stimulants, refer to therapy, or recommend further assessment is more trustworthy.
  • "100% diagnosis rate" or guaranteed outcomes. Legitimate services don't guarantee diagnoses. People who don't actually have ADHD shouldn't be diagnosed with it.

What's reasonable to vary

Not every imperfection is a red flag. Reasonable trade-offs:

  • Cash-pay vs insurance. Cash-pay services can be excellent and predictable; insurance-accepting services can be slow but cheaper. Both are fine choices.
  • Asynchronous vs video-based assessment. Video is more thorough; asynchronous can be appropriate for follow-ups or simpler cases. Some services blend.
  • State-restricted prescribing. Many services prescribe stimulants only in some US states due to state-by-state telehealth regulations. This isn't a quality issue — just check that yours is included.
  • Single-clinician vs network model. Both work. Network models offer redundancy if your clinician leaves; single-clinician services offer continuity.

Specific things to ask before paying

  1. Who is the clinician? What is their license and state?
  2. How long is the initial diagnostic visit?
  3. What scales and structured interviews do you use?
  4. Do you accept insurance for [my plan]? If so, what's my likely out-of-pocket?
  5. If I'm prescribed a stimulant, where will the prescription be sent? Is there a pharmacy restriction?
  6. What's the follow-up cadence? Are follow-ups included or billed separately?
  7. If I need to switch medications, what does that process look like?
  8. If I cancel my subscription mid-titration, what happens to my prescription?

Detailed comparison of 12+ services is on the services page. The cost & pathway tool shows realistic costs and timelines for your specific country and insurance situation.